ABCL
AbCellera Biologics Inc.Company with tickers: ABCL
CIK
1703057
CUSIP
00288U106
Shares Outstanding
305,375,393
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $4,235,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $66,895,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $42,496,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-62,660,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-45,621,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.15 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.15 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |